Daily ShareChat: Abano Healthcare

By Jenny Ruth

Abano Healthcare's first-half results show the company's underlying businesses have been hurt by the tough economic conditions but the results are still "surprisingly robust," given the vulnerablilty of many of the businesses to discretionary spending, says McDouall Stuart.

Excluding the $76.6 million net proceeds from the New Zealand Bay Audiology sale, the net profit was $3.4 million, down from $4.1 million last year, although the latest result includes only a five-month contribution from the sold business.

Operating profit fell slightly by 2%, implying that margins have tightened over the last six months and that breaks Abano's record of improving operating profit every year since 2006, the broker says.

The audiology sale has left the company with no New Zealand debt and a gearing ration of 15% relating to Australian dental debt after the company returned 52 cents per share to shareholders and an under-subscribed buyback. (The buyback was under-subscribed by $28.6 million with only $17.3 million taken up.)

Abano is in a strong position to continue its growth strategy through both greenfield investment and acquisition, McDouall Stuart says.

Its remaining businesses are less mature and lower margin but present better growth opportunities. "We continue to see Abano as a solidly managed company with excellent growth prospects."

BROKER CALL:  McDouall Stuart  rate Abano Healthcare as buy.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Printable version

Related News

Abano first-half profit falls on expansion costs; sales rise
New Deputy Chair for Abano
Abano flags softer bottom line in first-half on charges; revenue climbs
New Chairman for Abano Healthcare Group
Abano lifts revenue from continuing operations
Daily ShareChat: Abano Healthcare
Daily ShareChat: Abano Healthcare
Daily ShareChat: Abano Healthcare
Abano flags capital return after sale of National Hearing stake
Daily ShareChat: Abano

Get quotes for Abano Healthcare Group Limited Ordinary (ABA)

NZX Annoucements for ABA